Pelosi pursues articles of impeachment against Trump, says democracy at stake

Speaker of the House Nancy Pelosi responds forcefully to a question from a reporter who asked if she hated President Trump, after announcing earlier that the House is moving forward to draft articles of impeachment against Trump, at the Capitol in Washington, on Dec. 5, 2019. (AP Photo/J. Scott Applewhite)
Updated 06 December 2019

Pelosi pursues articles of impeachment against Trump, says democracy at stake

  • House panel could approve impeachment charges by Dec. 12
  • Trump assails “Do Nothing” Democrats, vows: “We will win!“

WASHINGTON: Warning that US democracy is at stake, House of Representatives Speaker Nancy Pelosi directed a congressional committee on Thursday to draft articles of impeachment against President Donald Trump, a historic step setting up a fight over whether to oust him from office.
In a dramatic televised statement, Pelosi accused the Republican president of abusing his power and alluded to Britain’s King George III, the monarch against whom the American colonies rebelled in forming the United States in 1776, saying that in the United States, “the people are the king.”
“Our democracy is what is at stake. The president leaves us no choice but to act because he is trying to corrupt, once again, the election for his own benefit. The president has engaged in abuse of power, undermining our national security and jeopardizing the integrity of our elections,” said Pelosi, the top Democrat in Congress.
At the heart of the Democratic-led House’s impeachment inquiry is Trump’s request that Ukraine launch an investigation targeting Joe Biden. The former vice president is a top contender for the Democratic nomination to face Trump in the 2020 presidential election.
“Sadly, but with confidence and humility, with allegiance to our founders and our heart full of love for America, today I am asking our chairman to proceed with articles of impeachment,” Pelosi said. She had opened the investigation in September.
She was referring to Jerrold Nadler, whose House Judiciary Committee has the responsibility of drawing up the formal charges that would later be voted on by the full House.
Two people knowledgeable about the process said the panel could draft and recommend the articles of impeachment to the House as early as Dec. 12. Democrats said lawmakers would work through the weekend to get them written.
The charges could include abuse of power, bribery, obstruction of Congress and obstruction of justice.

Senate trial
If articles of impeachment are passed as expected, that would lead to a trial in the Senate. Republicans, who control the Senate, have shown little support for convicting and removing him.
Pelosi was asked what it would take for Republicans to support impeachment as she took questions at a Town Hall on CNN on Thursday night. “I can’t answer for the Republicans, they’ve taken an oath to Donald Trump,” she answered.
Trump, who has denied wrongdoing, wrote on Twitter: “The Do Nothing, Radical Left Democrats have just announced that they are going to seek to Impeach me over NOTHING.”
“The good thing is that the Republicans have NEVER been more united. We will win!” Trump said.
Pelosi’s announcement clearly signaled that she believes Democrats have the votes in the 435-seat House to impeach. She acted after receiving overwhelming support in a party meeting on Wednesday night, a source familiar with the meeting said.
The impeachment drama is unfolding at a time of deep partisan divisions across the United States that have widened during Trump’s tumultuous presidency.
The inquiry’s focus is a July 25 telephone call in which Trump asked Ukrainian President Volodymyr Zelenskiy to open an investigation into Biden and his son Hunter, and a discredited theory promoted by Trump and his allies that Ukraine, not Russia, meddled in the 2016 US election.
Hunter Biden had joined the board of Ukrainian energy company Burisma while his father was vice president. Trump has accused the Bidens of corruption. They have denied wrongdoing and the allegations have not been substantiated.

Security aid
Democrats have accused Trump of abusing his power by withholding $391 million in security aid to Ukraine — a vulnerable US ally facing Russian aggression — as leverage to pressure Kiev into conducting investigations politically beneficial to Trump.
Republicans accuse Democrats of trying to overturn the results of the 2016 election. They have described Trump’s actions as aimed at weeding out corruption in Ukraine, not getting political dirt on Biden.
They also argue the inquiry has failed to produce first-hand evidence showing Trump made US aid to Ukraine or a White House meeting for its president contingent on Kiev pursuing the investigations.
On Wednesday, the Judiciary Committee held a hearing in which three constitutional law experts called by Democratic lawmakers said Trump had committed impeachable offenses. A fourth expert called by Republicans called the inquiry slipshod and rushed.
Nadler has given Trump until 5 p.m. (2200 GMT) on Friday to say whether he or his legal counsel will participate in upcoming proceedings by calling witnesses, introducing evidence and making a presentation. Nadler has given committee Republicans the same deadline to request witnesses.
Judiciary Democrats said the report by former Special Counsel Robert Mueller documenting Russian interference in the 2016 election could be part of testimony they hear on Monday from a committee lawyer, who is presenting evidence along with a Democratic lawyer from the House Intelligence Committee. Republican committee lawyers are also expected to testify.
Including material from Mueller’s report in an article of impeachment would demonstrate a pattern of behavior involving foreign interference in US elections, House Judiciary Democrat Pramila Jayapal said.
“What we have to think about is what gives us the strongest trial in the Senate,” she told reporters.
The US Constitution empowers the House to impeach a president for “treason, bribery or other high crimes and misdemeanors.”
No US president has ever been removed from office through impeachment. Republican Richard Nixon resigned in 1974 after the House began the process in the Watergate corruption scandal.
Two other presidents were impeached by the House but acquitted by the Senate.
In 1998, a Republican-led House passed articles of impeachment against Democratic President Bill Clinton, charges arising from a sexual relationship he had with a White House intern. The other president impeached by the House but left in office by the Senate was Andrew Johnson in 1868, three years after the US Civil War.
Asked if he worried that impeachment would tarnish his legacy, Trump told reporters at the White House: “No, not at all, not at all. It’s a hoax, it’s a big fat hoax.”

Indonesia begins human trials of anti-virus vaccine

Updated 2 min 6 sec ago

Indonesia begins human trials of anti-virus vaccine

  • The vaccine candidate, produced by Sinovac Biotech, is among just a few in the world to enter Phase 3 clinical trials
  • The treatment, known as CoronaVac, is already being tested on 9,000 health workers in Brazil

JAKARTA: Indonesia is stepping up efforts to find a COVID-19 vaccine by launching human trials of a potentially effective drug amid criticism of its lacklustre handling of the pandemic and concerns about its plummeting economy.

The third phase of the clinical trials of the vaccine — which is manufactured by China’s Sinovac Biotech in collaboration with its Indonesian pharma counterpart, Bio Farma — began on Tuesday and is being conducted by the Padjadjaran University School of Medicine at six locations in Bandung, West Java province, where the university and the state-owned pharma company are based.

“The first day of the trial went well, with 20 volunteers in each of the six locations injected with the potential vaccine. We have no complaints so far, and we are preparing the second injection batch on Aug 14,” Iwan Setiawan, a spokesman for Bio Farma, told Arab News on Wednesday.

He added that the six-month trial would require the participation of 1,620 volunteers who were “in good health and had not tested positive” for the disease.

Ridwan Kamil, governor of West Java, Indonesia’s most populated province, is among the volunteers who have signed up for the trial.

The third phase is a must before the vaccine, known as CoronaVac, goes into the production stage and is a prerequisite for all pharmaceutical products, including medicines and vaccines.

“The potential vaccine had gone through three trials; the pre-clinical, the clinical trial first phase and the second phase in China,” Bio Farma CEO Honesti Basyir said in a statement.

According to Basyir, Sinovac is one of the few institutions that have progressed to the third phase of the clinical trial from among hundreds of research institutions around the world that are developing the COVID-19 vaccine.

According to Oxford Business Group’s COVID-10 Economic Impact Assessment, there are more than 150 different vaccines that international researchers are working on. However, only 26 have reached the human trial stage so far.

Once the trials are concluded, Bio Farma will register the vaccine with the Food and Drug Supervisory Agency so that it can begin mass-production of the drug.

“We have prepared a production facility for the COVID-19 vaccine with a maximum capacity of 100 million dosages, and by the end of December this year we will have an increased production capacity to produce an additional 150 million dosages,” Basyir said.

President Joko Widodo oversaw the first injections to the batch of volunteers in one of the six locations and also toured Bio Farma’s production facility. 

“We hope this clinical trial would conclude in six months and so we can start producing the vaccine in January and vaccinate our people soon,” Widodo said.

State-Owned Enterprise Minister Erick Thohir, who is also the head of the COVID-19 mitigation and national economic recovery committee, said that Bio Farma was a well-established vaccine producer whose products were halal-compliant and used in 150 countries, including in the Middle East.

The collaboration with Sinovac is one of three vaccine-development projects that Indonesia is engaging in with foreign parties as it grapples with a surge in infections. At the same time, social restrictions and economic activities were eased. The other two projects are with South Korea’s Genexine and Norway’s Coalition for Epidemic, Preparedness and Innovation.

As of Wednesday, Indonesia had reported 130,718 infections with 1,942 new cases, 85,798 recoveries and 5,903 deaths, although experts suggest that the numbers could be higher due to the country’s low testing capacity.

Cases also surged in the capital Jakarta with workplaces emerging as the new infection clusters after thousands of employees returned to work recently.